Inscripta – The Digital Genome Engineering Company

Inscripta is developing the world’s first scalable platform for benchtop digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, reagents, and software, offers a fully automated workflow that enables multiplexed, trackable editing of cells at an unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7 CRISPR nuclease free for research purposes, the company enables scientists to realize a new era of biological discovery.

If you would like to learn more about Inscripta you can visit their website at or view the videos and applications below:

See examples of applications using the Onyx technology:

This content was supplied by Inscripta.